Effects of refeeding diets on emeriamine-induced fatty liver in fasting rats

Journal of Nutritional Science and Vitaminology

Volumn 42, Issue 5, 1996, Pages 469-478

  Maeda, Hideo ^a   Fujiwara, Miho ^a   Miyamoto, Kana ^a   Hamamoto, Hidetoshi ^b   Fukuda, Nobuhiro ^c  

^a NARUTO UNIVERSITY OF EDUCATION   (Japan)

^b Tag Biosystem Institute   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

dietary composition; emeriamine; fatty acid; fatty liver; glycogen; high carbohydrate diet; high fat diet; triglyceride

Indexed keywords

CARBOHYDRATE; CARNITINE DERIVATIVE; EMERIAMINE; GLYCOGEN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FATTY LIVER; LIVER; NONHUMAN; NUTRITION; RAT; SERUM;

ANIMALIA;

EID: 0029834899     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.42.469     Document Type: Article

References (23)

1. Mayes, P. A., and Felts, J. M. (1967): Regulation of fat metabolism in the liver. Nature, 215, 716-718.
2. McGarry, J. D., and Foster, D. W. (1980): Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem., 49, 395-420.
3. Kanamaru, T., Shinagawa, S., Asai, M., Okazaki, H., Sugiyama, Y., Fujita, T., Iwatsuka, H., and Yoneda, M. (1985): Emeriamine, an antidiabetic β-aminobetaine derived from a novel fungal metabolite. Life Sci., 37, 217-223.
4. Kanamaru, T., and Okazaki, H. (1989): Emeriamine: a new inhibitor of long-chain fatty acid oxidation and its antidiabetic activity. in Novel Microbial Products for Medicine and Agriculture, ed. by Demain, A. L., Somkuti, G. A., Hunter-Cevera, J. C., and Rossmoore, H. W., Society for Industrial Microbiology, Elsevier, New York, pp. 135-144.
5. Maeda, H., Fujiwara, M., Fujita, K., and Fukuda, N. (1996): Hypertriglyceridemia and fatty liver of fasting rats after administration of emeriamine. J. Nutr. Sci. Vitaminol., 42, 111-120.
6. Folch, J., Lees, M., and Sloane-Stanley, G. H. (1957): A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509.
7. Johnson, J. A., and Fusaro, R. M. (1966): The quantitative enzymic determination of animal liver glycogen. Anal. Biochem., 15, 140-149.
8. Gornall, A. G., Bardawill, C. S., and David, M. M. (1949): Determination of serum proteins by means of the biuret reaction. J. Biol. Chem., 177, 751-766.
9. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
10. Fukuda, N., and Ontko, J. A. (1984): Interactions between fatty acid synthesis, oxidation, and esterification in the production of triglyceride-rich lipoproteins by the liver. J. Lipid Res., 25, 831-842.
11. McCune, S. A., and Harris, R. A. (1979): Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. J. Biol. Chem., 254, 10095-10101.
12. Yamamoto, M., Fukuda, N., Triscari, J., Sullivan, A. C., and Ontko, J. A. (1985): Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654. J. Lipid Res., 26, 1196-1204.
13. Ide, T., and Ontko, J. A. (1981): Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver. J. Biol. Chem., 256, 10247-10255.
14. Yamamoto, M., and Nakamura, Y. (1994): Inhibition of β-oxidation by 3-mercaptopropionic acid produces features of Reye's syndrome in perfused rat liver. Gastroenterology, 107, 517-524.
15. Jenkins, D. L., and Griffith, O. W. (1985): DL-Aminocarnitine and acetyl-DL-aminocarnitine: potent inhibitors of carnitine acyltransferases and hepatic triglyceride catabolism. J. Biol. Chem., 260, 14748-14755.
16. Jenkins, D. L., and Griffith, O. W. (1986): Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines. Proc. Natl. Acad. Sci. USA, 83, 290-294.
17. Yasuhara, M., Ohama, T., Matsuki, N., Saito, H., Shiga, J., Inoue, K., Kurokawa, K., and Teramoto, T. (1991): Induction of fatty liver by fasting in suncus. J. Lipid Res., 32, 887-891.
18. Ohama, T., Matsuki, N., Saito, H., Tsukamoto, K., Kinoshita, M., Katsuragawa, K., Okazaki, S., Yamanaka, M., and Teramoto, T. (1994): Effect of starving and refeeding on lipid metabolism in suncus. J. Biochem. (Tokyo), 115, 190-193.
19. Harano, Y., Kojima, H., Kashiwagi, A., Tanaka, Y., Nakamura, T., Fujita, T., and Shigeta, Y. (1987): A new carnitine analogue for the correction of metabolic derangements in diabetes. in Recent Trends in Management of Diabetes Mellitus, ed. by Sakamoto, N., Alberti, K. G. M. M., and Hotta, N., Elsevier, New York, pp. 567-571.
20. Wolf, H. P. O., Eistetter, K., and Ludwig, G. (1982): Phenylalkyloxirane carboxylic acids, a new class of hypoglycaemic substances: hypoglycaemic and hypoketonaemic effects of sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (B 807-27) in fasted animals. Diabetologia, 22, 456-463.
21. Wolf, H. P. O., and Engel, D. W. (1985): Decrease of fatty acid oxidation, ketogenesis and gluconeogenesis in isolated perfused rat liver by phenylalkyl oxirane carboxylate (B 807-27) due to inhibition of CPT1 (EC 2.3.1.21). Eur. J. Biochem., 146, 359-363.
22. Reaven, G. M., Chang, H., and Hoffman, B. B. (1988): Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Diabetes, 37, 28-32.
23. Barnett, M., Collier, G. R., and O'Dea, K. (1992): The longitudinal effect of inhibiting fatty acid oxidation in diabetic rats fed a high fat diet. Horm. Metab. Res., 24, 360-362.